Injection ports or sites are an important component of drug delivery systems used in medical treatment procedures like chemotherapy and parenteral nutrition. Injection ports provide convenient access to the vascular system through a non-coring needle and allow for repeated injection of drugs and fluids without disturbing vascular access. With the rising prevalence of chronic diseases and increasing healthcare expenditure globally, the demand for efficient drug delivery solutions is growing rapidly.
The global Injection Port Market is estimated to be valued at Us$ 1.57 Bn in 2024 and is expected to exhibit a CAGR Of 7.6% over the forecast period 2024 To 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The growing demand from the healthcare sector is one of the key trends driving the injection port market. With the increasing geriatric population suffering from multiple chronic conditions, the demand for parenteral drug delivery and long-term vascular access is surging. Injection ports help in efficient and repeated administration of drugs and IV fluids directly into the circulatory system with minimal puncture to veins. They play a vital role in cancer treatment procedures involving chemotherapy and can significantly improve treatment outcomes. The rising cancer prevalence worldwide has accelerated the uptake of injection ports across oncology facilities. Furthermore, technological advancement in port designs to improve biocompatibility and prevent blood clotting is also augmenting the market growth.
Segment Analysis
The global injection port market is dominated by Luer lock sub segment. It holds around 60% of total market share owing to its wide scope of applications for connecting tubing, transfer of fluids with syringes and ease of use. Catheter segment holds second largest share and is expected to witness fastest growth during forecast period.
Key Takeaways
The Global Injection Port Market Demand is expected to witness high growth over the forecast period of 2024 to 2031. The global Injection Port Market is estimated to be valued at US$ 1.57 Bn in 2024 and is expected to exhibit a CAGR of 7.6% over the forecast period 2024 to 2031.
Regional analysis shows North America dominating currently with over 35% share due to advanced healthcare facilities and increasing adoption of injection ports. Europe is second largest market and Asia Pacific is fastest growing region projected to expand at 9% CAGR during forecast period driven by rising healthcare expenditure and growing medical tourism in countries like India and China.
Key players operating in the injection port market are Jungbunzlauer, G. Mondini, Sentinel Rubber Works, B. Braun,Qosina, Bionic Medizintechnik, Elcam Medical, ICU Medical and BD among others. Jungbunzlauer leads the market with over 20% share owing to its wide product portfolio and global presence. G. Mondini is second largest player focusing to expand in emerging Asian markets through partnerships. Qosina and BD are also prominent players focusing on new product launches catering to safety standards.
Get more insights on this topic :
Check more trending articles on this topic:
